- Treprostinil, stable prostacyclin analogue, in the treatment of pulmonary arterial hypertension2006 | First Faculty of Medicine
- Long term experience with treprostinil infusion treatment in patients with pulmonary arterial hypertension in the Czech Republic2007 | First Faculty of Medicine
- The risk profile change in patients with severe chronic thromboembolic pulmonary hypertension treated with subcutaneous treprostinil2023 | Publication without faculty affiliation
- Subcutaneous treprostinil for the treatment of severe non-operable chronic thromboembolic pulmonary hypertension (CTREPH): a double-blind, phase 3, randomised controlled trial2019 | Publication without faculty affiliation
- První zkušenosti s intravenózním podáním treprostinilu u plicní arteriální hypertenze v ČRPublication without faculty affiliation
- Léčba plicní arteriální hypertenze kontinuální subkutánní infuzí treprostinilu - naše první zkušenostiPublication without faculty affiliation
- Long-term experience with implantable treprostinil pumps in pulmonary arterial hypertension2020 | First Faculty of Medicine
- Prostanoids in the treatment of pulmonary arterial hypertension2008 | First Faculty of Medicine
- Predictors of long-term outcomes in patients treated with riociguat for pulmonary arterial hypertension: data from the PATENT-2 open-label, randomised, long-term extension trial2016 | First Faculty of Medicine
- Macitentan and Morbidity and Mortality in Pulmonary Arterial Hypertension2013 | First Faculty of Medicine
- Macitentan in Pulmonary Arterial Hypertension: A Focus on Combination Therapy in the SERAPHIN Trial2018 | First Faculty of Medicine
- Moderní možnosti v léčbě plicní hypertenze2022 | First Faculty of Medicine